Atlas Trials

A Study to Evaluate the Efficacy and Safety of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)

Clinical trial NCT02283957 · COMPLETED

Trial details

NCT number
NCT02283957
Sponsor
Centrexion Therapeutics
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Painful Intermetatarsal Neuroma (Morton's Neuroma)
Start date
2014-10-01
Primary completion
2015-08-01
Enrollment
119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.